The relationship between healthcare companies and physicians is complex, presenting potential conflicts of interest that require oversight. Biopharmaceutical and medical device companies operate in a highly competitive market.  As a result, some companies may seek an advantage by extending gifts or other inappropriate inducements to healthcare professionals to promote a specific drug or medical equipment. […]

Flexing its regulatory muscle, the Food and Drug Administration has warned it would l issue sanctions to pharmaceutical companies which do not comply with the guidelines in following the Mexico City Principles or voluntary code of ethics. Read More at https://medicalobserverph.com/

The Food and Drug Administration (FDA) will issue sanctions to pharmaceutical companies who will not comply with the guidelines in following the Mexico City Principles (MCP) or voluntary code of ethics. Read More at http://balita.ph/